Lutonix Competitors and Similar CompaniesClear all
Lutonix's competitors and similar companies include Intra-Cellular Therapies, Histocell, Kanghong Pharmaceutical and Neofluidics.
 Lutonix Lutonix DCB is a new drug-coated balloon catheter that delivers paclitaxel to the arterial wall in a single, short inflation. |  Intra-Cellular Therapies Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS. |  Histocell Histocell is a biopharmaceutical company focused on the development, manufacturing, and commercialization of medical devices, active ingredients, and cell therapy drugs for regenerative medicine. |  Kanghong Pharmaceutical Kanghong Pharmaceutical (成都康弘药业集团股份有限公司) is a company that produces and sells biological products. | ||
Founding Date | Founding Date 2007 | Founding Date 2002 | Founding Date 2011 | Founding Date 1996 | Founding Date 2014 |
Type | Type Subsidiary | Type Public | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Maple Grove, US HQ | Locations New York, US HQ | Locations Derio, ES HQ Larrabetzu, ES | Locations Cheng Du Shi, CN HQ | Locations San Diego, US HQ Lubbock, US |
Employees | Employees 10 | Employees 330352% increase | Employees 365% decrease | Employees 4,462 | Employees 3 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 8.1 b | Valuation ($) N/A | Valuation ($) 2.5 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $680.9m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) ¥4.5b (FY, 2025) | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($74.7m) (FY, 2024) | Net income N/A | Net income ¥1.1b (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 35m | Total funding raised $ 225.3m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 3.2m |
For sources of this data, please see the company profile
View Company Profiles
Intra-Cellular Therapies
HQ
New York, US
Employees
330
Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS.
View companyHistocell
HQ
Derio, ES
Employees
36↓ 5% decrease
Histocell is a biopharmaceutical company focused on the development, manufacturing, and commercialization of medical devices, active ingredients, and cell therapy drugs for regenerative medicine.
View companyKanghong Pharmaceutical
HQ
Cheng Du Shi, CN
Employees
4,462
Kanghong Pharmaceutical (成都康弘药业集团股份有限公司) is a company that produces and sells biological products.
View company
Neofluidics
HQ
San Diego, US
Employees
3
Neofluidics is a company that develops tools and technology for enhanced microfluidics.
View company